Nancy Lynn Md Snyderman Alkermes Plc. (ALKS) insider trading activity

Nancy Lynn Md Snyderman is Director of Alkermes plc.. Currently has a direct ownership of 10,728 shares of ALKS, which is worth approximately $314,866. The most recent transaction as insider was on May 31, 2025, when has been sold 1,924 shares (Ordinary Shares) at a price of $30.61 per share, resulting in proceeds of $58,893. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K

131.26% 3M change

48.38% 12M change

Total Value Held $314,866

nancy lynn MD snyderman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2025	SELL Payment of exercise price or tax liability	$58,893 $30.61 p/Share	1,924 Reduced 15.21%	10,728 Ordinary Shares
May 31 2025	BUY Exercise of conversion of derivative security	-	8,013 Added 38.78%	12,652 Ordinary Shares
Jun 29 2024	SELL Payment of exercise price or tax liability	$35,306 $24.1 p/Share	1,465 Reduced 24.0%	4,639 Ordinary Shares
Jun 29 2024	BUY Exercise of conversion of derivative security	-	6,104 Added 50.0%	6,104 Ordinary Shares
Jul 07 2023	SELL Payment of exercise price or tax liability	$42,728 $29.88 p/Share	1,430 Reduced 6.44%	20,783 Ordinary Shares
Jul 07 2023	BUY Exercise of conversion of derivative security	-	5,957 Added 21.15%	22,213 Ordinary Shares
Jun 14 2022	SELL Payment of exercise price or tax liability	$18,897 $27.19 p/Share	695 Reduced 4.1%	16,256 Ordinary Shares
Jun 14 2022	BUY Exercise of conversion of derivative security	-	7,585 Added 30.91%	16,951 Ordinary Shares
Mar 04 2022	BUY Open market or private purchase	$10,005 $23.43 p/Share	427 Added 4.36%	9,366 Ordinary Shares
Dec 02 2021	SELL Payment of exercise price or tax liability	$29,605 $22.11 p/Share	1,339 Reduced 13.03%	8,939 Ordinary Shares
Dec 02 2021	BUY Exercise of conversion of derivative security	-	5,578 Added 35.18%	10,278 Ordinary Shares
May 20 2021	SELL Payment of exercise price or tax liability	$30,776 $21.92 p/Share	1,404 Reduced 23.0%	4,700 Ordinary Shares
May 20 2021	BUY Exercise of conversion of derivative security	-	6,104 Added 50.0%	6,104 Ordinary Shares

Also insider at

LYRA

Lyra Therapeutics, Inc. Healthcare

FHLTU

Future Health ESG Corp. Financial Services

Director

AXNX

Axonics, Inc. Healthcare

nlM